1-Acetyl-4-piperidineacetic acid

Catalog No.: 
ACRTIN791
CAS No.: 
78056-60-7
Molecular Formula: 
C9H15NO3
Molecular Weight: 
185.22
1-Acetyl-4-piperidineacetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$83.00In stockInquiry
25g98%$370.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Acetyl-4-piperidineacetic acid
IUPAC Name2-(1-acetylpiperidin-4-yl)acetic acid
MDL No.MFCD12027293
Molecular FormulaC9H15NO3
Molecular Weight185.22
SMILESO=C(O)CC1CCN(C(C)=O)CC1
InChI KeySPNAWRHVQZEFHH-UHFFFAOYSA-N
Synonym1-Acetyl-4-piperidineacetic acid | 78056-60-7 | 2-(1-acetylpiperidin-4-yl)acetic acid | (1-acetylpiperidin-4-yl)acetic acid | n-acetylpiperidine-4-acetic acid | MFCD12027293 | 1-Acetyl-4-piperidineaceticacid | SCHEMBL2422675 | DTXSID10439928 | SPNAWRHVQZEFHH-UHFFFAOYSA-N | 4
CAS No.78056-60-7
PubChem CID10442408

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACRTIN791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDHXK480 route compound structure diagram
    ACDHXK48073415-84-6In Stock
  4. Then
  5. ACRTIN791 route product structure diagram
    ACRTIN79178056-60-7In Stock
Inquiry

2. ACRTIN791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDHXK480 route compound structure diagram
    ACDHXK48073415-84-6In Stock
  2. Then
  3. ACRTIN791 route product structure diagram
    ACRTIN79178056-60-7In Stock
Inquiry

3. ACRTIN791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRTIN791 route product structure diagram
    ACRTIN79178056-60-7In Stock
Inquiry

Comments (0)